479 related articles for article (PubMed ID: 35955405)
1. The Role of Platelets in Diabetic Kidney Disease.
Rustiasari UJ; Roelofs JJ
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955405
[TBL] [Abstract][Full Text] [Related]
2. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms.
Xu C; Ha X; Yang S; Tian X; Jiang H
Front Endocrinol (Lausanne); 2023; 14():1232790. PubMed ID: 37859992
[TBL] [Abstract][Full Text] [Related]
3. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective.
Zheng W; Guo J; Liu ZS
Clin Epigenetics; 2021 Apr; 13(1):87. PubMed ID: 33883002
[TBL] [Abstract][Full Text] [Related]
4. Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules.
Tang J; Liu F; Cooper ME; Chai Z
Expert Opin Ther Targets; 2022 Aug; 26(8):721-738. PubMed ID: 36217308
[TBL] [Abstract][Full Text] [Related]
5. Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease.
Duan S; Sun L; Zhang C; Wu L; Nie G; Huang Z; Xing C; Zhang B; Yuan Y
Int Immunopharmacol; 2021 Apr; 93():107413. PubMed ID: 33524800
[TBL] [Abstract][Full Text] [Related]
6. Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities.
Aboolian A; Urner S; Roden M; Jha JC; Jandeleit-Dahm K
Handb Exp Pharmacol; 2022; 274():269-307. PubMed ID: 35318511
[TBL] [Abstract][Full Text] [Related]
7. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.
Chang TT; Li SY; Lin LY; Chen C; Chen JW
Biomed Pharmacother; 2023 May; 161():114450. PubMed ID: 36863097
[TBL] [Abstract][Full Text] [Related]
8. Update of pathophysiology and management of diabetic kidney disease.
Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
[TBL] [Abstract][Full Text] [Related]
9. Chronic Inflammation and Progression of Diabetic Kidney Disease.
Furuya F; Ishii T; Kitamura K
Contrib Nephrol; 2019; 198():33-39. PubMed ID: 30991405
[TBL] [Abstract][Full Text] [Related]
10. Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities.
Wang H; Liu D; Zheng B; Yang Y; Qiao Y; Li S; Pan S; Liu Y; Feng Q; Liu Z
Int J Biol Sci; 2023; 19(9):2678-2694. PubMed ID: 37324941
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease.
Cleveland KH; Schnellmann RG
Pharmacol Rev; 2023 Mar; 75(2):250-262. PubMed ID: 36781216
[TBL] [Abstract][Full Text] [Related]
12. LncRNA H19: a novel player in the regulation of diabetic kidney disease.
Wu Q; Huang F
Front Endocrinol (Lausanne); 2023; 14():1238981. PubMed ID: 37964955
[TBL] [Abstract][Full Text] [Related]
13. The genetic side of diabetic kidney disease: a review.
Song J; Ni J; Yin X
Int Urol Nephrol; 2023 Feb; 55(2):335-343. PubMed ID: 35974289
[TBL] [Abstract][Full Text] [Related]
14. The role of inflammation in diabetic kidney disease.
Jung SW; Moon JY
Korean J Intern Med; 2021 Jul; 36(4):753-766. PubMed ID: 34237822
[TBL] [Abstract][Full Text] [Related]
15. Inflammation in Diabetic Kidney Disease.
Pérez-Morales RE; Del Pino MD; Valdivielso JM; Ortiz A; Mora-Fernández C; Navarro-González JF
Nephron; 2019; 143(1):12-16. PubMed ID: 30273931
[TBL] [Abstract][Full Text] [Related]
16. The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease.
Tao P; Ji J; Wang Q; Cui M; Cao M; Xu Y
Front Immunol; 2022; 13():1080456. PubMed ID: 36601125
[TBL] [Abstract][Full Text] [Related]
17. Glomerular cell cross talk in diabetic kidney diseases.
Dong R; Xu Y
J Diabetes; 2022 Aug; 14(8):514-523. PubMed ID: 35999686
[TBL] [Abstract][Full Text] [Related]
18. The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease.
Gao Y; Su X; Xue T; Zhang N
Biomed Pharmacother; 2023 Jul; 163():114598. PubMed ID: 37150034
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.
Guo J; Liu Z; Gong R
Clin Sci (Lond); 2019 Jun; 133(12):1321-1339. PubMed ID: 31221822
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease.
Mao ZH; Gao ZX; Liu DW; Liu ZS; Wu P
Front Immunol; 2023; 14():1124704. PubMed ID: 36742307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
